QUADRANT CAPITAL GROUP LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1650717
CINCINNATI, OH
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$797,907
+$88,629 QoQ
Shares Held
23,551
+3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#357
of 675 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
|
13,278 | $695,767 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $797,907 | 23,551 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $709,278 | 22,726 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $442,178 | 21,890 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $447,475 | 26,699 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $303,603 | 19,753 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $96,469 | 4,377 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $61,772 | 3,428 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $39,390 | 2,424 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $28,798 | 2,041 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,586 | 1,493 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $24,061 | 2,359 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,710 | 360 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,965 | 1,691 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,655 | 1,278 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,375 | 914 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,008 | 1,065 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,375 | 253 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $8,746 | 1,092 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,662 | 376 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,900 | 293 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,646 | 316 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,586 | 268 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $801 | 89 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,528 | 124 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $137,194 | 15,278 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||